Literature DB >> 30030306

Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting.

Kyle M Fargen1, Kenneth Liu2, Rebecca M Garner1, Garret P Greeneway1, Stacey Q Wolfe1, R Webster Crowley3.   

Abstract

INTRODUCTION: Although venous sinus stenting (VSS) has emerged as a promising treatment option for patients with idiopathic intracranial hypertension (IIH) and associated venous sinus stenosis, there is considerable ambiguity regarding patient selection criteria, treatment protocols, and management strategies.
METHODS: An extensive literature review was performed to identify all reports of VSS in patients with IIH using PubMed. Recommendations for the selection and treatment of patients with IIH with VSS are outlined as determined based on author opinion from supporting studies. Due to the lack of randomized trials and few published prospective studies, standard grading scales for recommendations and level of evidence are not fully applicable and therefore a revised grading scale has been provided for recommendations.
RESULTS: The literature review identified a total of eight systematic reviews or meta-analyses and 29 published patient series on VSS. Recommendations for patient selection for diagnostic catheter angiography, angiography procedural considerations, stenting procedural considerations, and retreatment are provided based on the literature. Recommendations that were considered strong included: performance of venous sinus manometry to assess candidacy for treatment prior to stenting; administration of antiplatelet agents prior to stenting and for a follow-up period of at least 3-6 months; performance of post-stenting manometry to confirm resolution of pressure gradient; and performance of repeat angiography and manometry on patients with recurrence of symptoms after resolution with stenting to evaluate for recurrent stenosis.
CONCLUSION: VSS for patients with IIH with venous sinus stenosis is now an established and effective treatment option. These recommendations have been provided, based on a summative review of the available published literature, to assist in standardizing care for patients with IIH undergoing VSS. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  angiography; stent

Mesh:

Substances:

Year:  2018        PMID: 30030306     DOI: 10.1136/neurintsurg-2018-014042

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  14 in total

Review 1.  Cerebral Venous Outflow Implications in Idiopathic Intracranial Hypertension-From Physiopathology to Treatment.

Authors:  Sorin Tuță
Journal:  Life (Basel)       Date:  2022-06-08

2.  Prediction of the trans-stenotic pressure gradient with arteriography-derived hemodynamic features in patients with idiopathic intracranial hypertension.

Authors:  Yupeng Zhang; Chao Ma; Changxuan Li; Xiaoqing Li; Raynald Liu; Minke Liu; Haoyu Zhu; Fei Liang; Yilong Wang; Kehui Dong; Chuhan Jiang; Zhongrong Miao; Dapeng Mo
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-08       Impact factor: 6.960

3.  Intra-procedural cerebral sinus thrombosis during endovascular treatment of idiopathic intracranial hypertension.

Authors:  Jorge Arturo Larco; Mehdi Abbasi; Ramanathan Kadirvel; David F Kallmes; Luis E Savastano; Waleed Brinjikji
Journal:  Neuroradiol J       Date:  2022-04-29

4.  Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations.

Authors:  Robert Kyle Townsend; Alec Jost; Matthew R Amans; Ferdinand Hui; Matthew T Bender; Sudhakar R Satti; Robert Maurer; Kenneth Liu; Waleed Brinjikji; Kyle M Fargen
Journal:  J Neurointerv Surg       Date:  2021-04-28       Impact factor: 5.836

5.  Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.

Authors:  Philipp Hendrix; Christopher J Whiting; Christoph J Griessenauer; Christian Bohan; Clemens M Schirmer; Oded Goren
Journal:  Neurosurg Rev       Date:  2022-01-24       Impact factor: 3.042

6.  Perioperative mannitol intensive use may avoid the early complication of cerebral venous sinus stenting.

Authors:  Chaobo Bai; Jian Chen; Xiaoqin Wu; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Ann Transl Med       Date:  2020-06

Review 7.  Advances in the understanding of headache in idiopathic intracranial hypertension.

Authors:  Susan P Mollan; Jan Hoffmann; Alexandra J Sinclair
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

8.  A proposed framework for cerebral venous congestion.

Authors:  Anirudh Arun; Matthew R Amans; Nicholas Higgins; Waleed Brinjikji; Mithun Sattur; Sudhakar R Satti; Peter Nakaji; Mark Luciano; Thierry Agm Huisman; Abhay Moghekar; Vitor M Pereira; Ran Meng; Kyle Fargen; Ferdinand K Hui
Journal:  Neuroradiol J       Date:  2021-07-05

9.  Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.

Authors:  Aqib H Zehri; Katriel E Lee; Jeff Kartchner; Madison Arnel; Timothy Martin; Stacey Q Wolfe; Kyle M Fargen
Journal:  Neuroradiol J       Date:  2021-07-05

10.  Intracranial Venous Hypertension and Venous Sinus Stenting in the Modern Management of Idiopathic Intracranial Hypertension.

Authors:  Robert K Townsend; Kyle M Fargen
Journal:  Life (Basel)       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.